We are live on ! Find out more
GL

GLG LLC Portfolio holdings

AUM $1.39B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+5.82%
1 Year Est. Return
+24.01%
3 Year Est. Return
+43.2%
5 Year Est. Return
10 Year Est. Return
AUM
$1.4B
AUM Growth
+$71.7M
Cap. Flow
-$26.6M
Cap. Flow %
-1.9%
Top 10 Hldgs %
17.58%
Holding
554
New
75
Increased
71
Reduced
347
Closed
50

Sector Composition

Rank Sector Weight
1 Healthcare 12.53%
2 Financials 11.31%
3 Technology 9.48%
4 Energy 9.24%
5 Communication Services 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDVN
551
DELISTED
MEDIVATION, INC.
MDVN
-9,776
Closed -$589K

Similar funds

GLG LLC's Q3 2016 Portfolio in Review

As of Q3 2016, GLG LLC held 554 positions worth $1.4B, up 5.4% from $1.33B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

GLG LLC's Q3 2016 filing shows 75 new, 71 increased, 347 reduced and 50 closed positions. Its largest new stake was Johnson Controls International: 240,230 shares worth $11.2M. The largest sale was Johnson & Johnson, an estimated $10.5M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 13% a quarter earlier, followed by Financials and Technology.

  • GLG LLC's largest Q3 2016 buy was Johnson Controls International: 240,230 shares worth $11.2M.
  • GLG LLC added most to Pfizer in Q3 2016, an estimated $7.76M increase.
  • GLG LLC's biggest Q3 2016 reduction was Johnson & Johnson, cutting an estimated $10.5M.
  • GLG LLC fully exited Monsanto Co in Q3 2016, selling an estimated $4.82M.
  • GLG LLC's ten largest holdings make up 18% of its $1.4B portfolio in Q3 2016.
  • GLG LLC opened 75 new positions and closed 50 in Q3 2016.
  • GLG LLC's portfolio value rose 5.4% quarter-over-quarter to $1.4B.

Based on GLG LLC's 13F filing for Q3 2016, filed 14 Nov 2016.